Inotiv, Inc. — Board/Management Information 2004

Aug 20, 2004

8-K 1 basform8k.htm BIOANALYTICAL SYSTEMS, INC. 8K Bioanalytical Systems, Inc. - Form 8K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): August 19, 2004

BIOANALYTICAL SYSTEMS, INC. (Exact name of registrant as specified in its charter)

Indiana	0-23357	35-1345024
(State or other jurisdiction of incorporation or organization)	(Commission File Number)	(IRS Employer Identification No.)
2701 Kent Avenue West Lafayette, Indiana		47906-1382
(Address of principal executive offices)		(Zip Code)
	(765) 463-4527
	(Registrant's telephone number, including area code)

MARKER FORMAT-SHEET="Body - No Indent" FSL="Workstation"

The information in this Form 8-K is being furnished and shall not be deemed “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. The information in this Form 8-K shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended.

MARKER FORMAT-SHEET="Indented Head Left" FSL="Workstation"

Item 7. Financial Statements and Exhibits.

(a) Not applicable.

(b) Not applicable.

(c) Exhibits

99.1 Bioanalytical Systems, Inc. press release, issued August 19, 2004.

MARKER FORMAT-SHEET="Body - No Indent" FSL="Default"

Item 9. Regulation FD Disclosure.

On August 19, 2004, Bioanalytical Systems, Inc. (the "Company") issued a press release announcing that Gayl W. Doster has been elected to its Board of Directors.

MARKER FORMAT-SHEET="Body - No Indent" FSL="Default"

The full text of the press release is furnished as exhibit 99.1 to this Form 8-K.

MARKER FORMAT-SHEET="ARTICLE bold" FSL="Workstation"

SIGNATURES

MARKER FORMAT-SHEET="Para Indent Lv 0-TNR" FSL="Default"

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

MARKER FORMAT-SHEET="Signature Block w/Company Name" FSL="Workstation"

Date: August 19, 2004 Bioanalytical Systems, Inc. By: /s/ Michael R. Cox Michael R. Cox VP-Finance, Chief Financial Officer and Treasurer

MARKER FORMAT-SHEET="Heading Center Bold" FSL="Workstation"

Exhibit Index

MARKER FORMAT-SHEET="Signature Block w/Company Name" FSL="Workstation"

Exhibit No. 99.1 Description Bioanalytical Systems, Inc. press release, issued August 19, 2004.